NervGen Pharma Q3 EPS $(0.04) Beats $(0.12) Estimate

Benzinga · 1d ago
NervGen Pharma (NASDAQ:NGEN) reported quarterly losses of $(0.04) per share which beat the analyst consensus estimate of $(0.12) by 66.67 percent.